ConductScience.org, home

Paper22845893

Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.

Gatti A and 5 others. Pain Med, 2012. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. Papers, record 22845893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22845893

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
PubMed
Journal
Pain Med
PubMed
Year
2012
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
3.06
iCite
Revised in PubMed
2020-12-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gatti AAntonio
2Lazzari MMarzia
3Gianfelice VValentina
4Di Paolo AAnnarita
5Sabato EElisabetta
6Sabato AFAlessandro Fabrizio

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Chronic PainMajor topic
EndocannabinoidsMajor topic
EthanolaminesMajor topic
Palmitic AcidsMajor topic
Adult
Aged
Aged, 80 and over
Amides
Female
Humans
Male
Middle Aged
Treatment Outcome
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in23581707Emerging neuroprotective effects of N-palmitoylethanolamide besides its significant antinociceptive effects.https://conductscience.org/library/papers/23581707PubMed
Comment in23614877Response to dr. Kapoor.https://conductscience.org/library/papers/23614877PubMed

Download CSV of comments and corrections

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42356281Palmitoylethanolamide/Baicalin Supplementation and Changes in Pain and Sudomotor Function in Type 2 Diabetes: A Retrospective Matched Real-World Cohort Study.Nutrients2026https://conductscience.org/library/papers/42356281PubMed
41709243Probiotics and palmitoylethanolamide (PEA) for osteoarthritic pain: individual effects in a multiple baseline design study.BMC Complement Med Ther2026https://conductscience.org/library/papers/41709243PubMed
41693292Palmitoylethanolamide (PEA) regulates cell cycle progression and promotes an anti-inflammatory transcriptomic signature in C2C12 skeletal muscle cells.Physiol Rep2026https://conductscience.org/library/papers/41693292PubMed
41390289Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid on neurosteroid and neuroinflammatory dysregulation in autism spectrum disorders.Neurotherapeutics2026https://conductscience.org/library/papers/41390289PubMed
41142233Pharmacologic treatment of fibromyalgia: an update.Front Pharmacol2025https://conductscience.org/library/papers/41142233PubMed
40853095Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl-L-Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain.Eur J Neurol2025https://conductscience.org/library/papers/40853095PubMed
40563990Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation.Biomedicines2025https://conductscience.org/library/papers/40563990PubMed
39630391A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review.Pain Ther2025https://conductscience.org/library/papers/39630391PubMed
39330506Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis.Metabolites2024https://conductscience.org/library/papers/39330506PubMed
39062193Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study.Biomedicines2024https://conductscience.org/library/papers/39062193PubMed
38892586Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis.Nutrients2024https://conductscience.org/library/papers/38892586PubMed
38792328Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept Study.J Clin Med2024https://conductscience.org/library/papers/38792328PubMed
38790962Amelioration of Dextran Sodium Sulfate-Induced Colitis in Mice through Oral Administration of Palmitoylethanolamide.Biomedicines2024https://conductscience.org/library/papers/38790962PubMed
38399360
Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study.
Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38399360PubMed
37550909Neuropathic Pain in Aged People: An Unresolved Issue Open to Novel Drug Approaches, Focusing on Painful Diabetic Neuropathy.Curr Neuropharmacol2024https://conductscience.org/library/papers/37550909PubMed
37370671Quantification of Analgesic and Anti-Inflammatory Lipid Mediators in Long-Term Cryopreserved and Freeze-Dried Preserved Human Amniotic Membrane.Bioengineering (Basel)2023https://conductscience.org/library/papers/37370671PubMed
36638082Distribution of an analgesic palmitoylethanolamide and other N-acylethanolamines in human placental membranes.PLoS One2023https://conductscience.org/library/papers/36638082PubMed
36015298Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence.Pharmaceutics2022https://conductscience.org/library/papers/36015298PubMed
35926992Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.BMJ Open2022https://conductscience.org/library/papers/35926992PubMed
35578721Looking for Responders among Women with Chronic Pelvic Pain Treated with a Comicronized Formulation of Micronized Palmitoylethanolamide and Polydatin.Biomed Res Int2022https://conductscience.org/library/papers/35578721PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22845893

GET https://conductscience.org/api/papers/v1/22845893/cited_by?page=2